Congress Weighs Who Should Have the ‘Right To Try’
There is renewed energy around a policy that would allow seriously ill patients access to experimental therapies, but lawmakers are debating who should be given this benefit.
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.